SAN DIEGO--(BUSINESS WIRE)--In a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Producing the T lymphocytes that are increasingly being used to fight cancer and other diseases may soon be faster and more efficient, thanks to research being conducted at the University of British ...

Proteintech Group, the benchmark in antibodies, today announces an agreement to purchase HumanZyme. HumanZyme is a leading manufacturer of recombinant human proteins. Their proprietary human ...

Moss is an often-overlooked, ancient plant that is far from insignificant. Among the first to colonize land, mosses greened the planet and transformed Earth’s climate, providing an oxygen-rich ...

Most mutations that cause disease by swapping one amino acid out for another do so by making the protein less stable, according to a major study of human protein variants that was published in Nature ...

A comprehensive analysis of over 500,000 human protein variants reveals that 60% of disease-causing missense mutations reduce protein stability In a recent study published in Nature, researchers used ...